Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Arthritis & Rheumatism

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1529-0131(200011)43:11<2606::AID-ANR31>3.0.CO;2-XPMID 11083287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.

  2000cited by this paper
• A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

  1999cited by this paper
• Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

  1999cited by this paper
• Prediction Equation for Glomerular Filtration Rate

  1999cited by this paper
• Etanercept Therapy in Rheumatoid Arthritis

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

  1999cited by this paper
• Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study.

  1996cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats.

  1992cited by this paper
• Juvenile rheumatoid arthritis in children with diabetes mellitus.

  1981cited by this paper

• Diabetic complications and prospective immunotherapy

  2023cites this paper
• TNF-α-TNFR1 Signaling Mediates Inflammation and Bone Resorption in Apical Periodontitis.

  2023cites this paper
• Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review).

  2022cites this paper
• The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases

  2022cites this paper
• Effect of inflammatory bowel disease treatments on patients with diabetes mellitus

  2021cites this paper
• Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets

  2020cites this paper
• Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases.

  2020cites this paper
• TNFR signalling and its clinical implications

  2018cites this paper
• TNFR1 and TNFR2 signalling and its clinical implications

  2017cites this paper
• J Endocrinol 2017, 1(2): 000107

  2017cites this paper
• Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes

  2017cites this paper
• The role of TNF-α in rheumatoid arthritis: a focus on regulatory T cells

  2016cites this paper
• Tumor Necrosis Factor Inhibitors in Pediatric Rheumatology

  2016cites this paper
• Chapter 13 – Pharmacology: Biologics

  2016cites this paper
• Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes

  2016cites this paper
• the immune response autoimmunity: possible interactions of genes, sex, and B in κ A role for transcription factor NF-

  2015cites this paper
• Control and induction of tumor necrosis factor and its receptors on human lymphocytes: a critical structure for immune regulation

  2015cites this paper
• Regulation of tumour necrosis factor signalling: live or let die

  2015cites this paper
• TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects

  2015cites this paper
• Метаболический синдром при ревматоидном артрите

  2013cites this paper
• Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto’s thyroiditis successfully treated with etanercept

  2013influential citation
• Update on biologicals for treatment of juvenile idiopathic arthritis

  2013cites this paper
• Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease

  2013cites this paper
• DIABETIC STUDIES The Review of Immunotherapy in Autoimmune Type 1 Diabetes

  2013cites this paper
• Type III Polyglandular Autoimmune Syndromes in children with type 1 diabetes mellitus.

  2013cites this paper
• Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever.

  2013cites this paper
• Immunotherapy in autoimmune type 1 diabetes.

  2012cites this paper
• Case Report Of A Child With Recently Diagnosed Diabetes Mellitus Type 1 And Subsequent Systemic Arthritis

  2012cites this paper
• Prevention Strategies for Type 1 Diabetes Mellitus

  2012cites this paper
• Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

  2012cites this paper
• Wczesna diagnostyka i monitorowanie zapalenia błony naczyniowej oka u dzieci i młodzieży z rozpoznanym młodzieńczym idiopatycznym zapaleniem stawów

  2012cites this paper
• Erlotinib and gefitinib, small-molecule EGFR inhibitors. New uses for old drugs?:

  2012cites this paper
• Simultaneous Juvenile Idiopathic Arthritis and Diabetes Mellitus Type 1 — A Finnish Nationwide Study

  2012cites this paper
• Safe and Effective Medicines for Children

  2012cites this paper
• Role of Novel Biological Therapies in Psoriatic Arthritis

  2012cites this paper
• [Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].

  2011cites this paper
• [Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience].

  2011cites this paper
• Type 1 diabetes: etiology, immunology, and therapeutic strategies.

  2011cites this paper
• Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA)

  2011cites this paper
• PHARMACOLOGY AND DRUG THERAPY

  2011cites this paper
• Генно-инженерная биологическая терапия ювенильного артрита

  2011cites this paper
• Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes

  2011cites this paper
• The safety profile of biologic therapies for juvenile idiopathic arthritis

  2010cites this paper
• Critical Role for TNF in the Induction of Human Antigen-Specific Regulatory T Cells by Tolerogenic Dendritic Cells

  2010cites this paper
• This information is current as by Tolerogenic Dendritic Cells Human Antigen-Specific Regulatory T Cells Critical Role for TNF in the Induction of and

  2010cites this paper
• The Hospital for Sick Children Technology Assessment at Sick Kids ( TASK ) THE USE OF BIOLOGIC RESPONSE MODIFIERS IN POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS

  2010cites this paper
• Effects of tumor necrosis factor‐α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis

  2009cites this paper
• Challenges in the management of juvenile idiopathic arthritis with etanercept

  2009cites this paper
• Development of type 1 diabetes in a patient treated with anti-TNF-α therapy for active rheumatoid arthritis

  2009cites this paper
• Recurrent hyperglycemia during adalimumab treatment in a patient with psoriasis.

  2008cites this paper
• Development of autoimmune hepatitis in a child with systemic-onset juvenile idiopathic arthritis during therapy with etanercept.

  2008cites this paper
• Are Insights Gained from NOD Mice Sufficient to Guide Clinical Translation?

  2007cites this paper
• Serious liver disease induced by infliximab

  2007cites this paper
• Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

  2007cites this paper
• Le terapie biologiche con inibitori del TNF in reumatologia pediatrica. Revisione della letteratura ed esperienza personale Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

  2007cites this paper
• Chapter 18 TNF-Inhibitors in Pediatric Rheumatology

  2007cites this paper
• response possible interactions of genes , sex , and the immune B in autoimmunity : κ A role for transcription factor

  2006cites this paper
• Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.

  2006cites this paper
• Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune Arthritis

  2006cites this paper
• Aktuelle Therapie der juvenilen idiopathischen Arthritis mit Biologika

  2006cites this paper
• A role for transcription factor NF-κB in autoimmunity: possible interactions of genes, sex, and the immune response

  2006cites this paper
• Effetti collaterali del trattamento con inibitori del TNFα nell'artrite idiopatica giovanile* Side effects of anti-TNFα therapy in juvenile idiopathic arthritis

  2006cites this paper
• Therapie der juvenilen idiopathischen Arthritis mit TNF-α-Antagonisten

  2006cites this paper
• O papel dos inibidores do fator de necrose tumoral no tratamento da artrite idiopática juvenil

  2006cites this paper
• Staying Current A role for transcription factor NF-B in autoimmunity : possible interactions of genes , sex , and the immune response

  2006cites this paper
• [Importance of the new biologicals and cytokine antagonists in the treatment of juvenile idiopathic arthritis (JIA)].

  2005cites this paper
• Methods to characterize lymphoid apoptosis in a murine model of autoreactivity.

  2005cites this paper
• Medical treatment of juvenile idiopathic arthritis.

  2005cites this paper
• Taiwan experience with etanercept in juvenile rheumatoid arthritis.

  2005cites this paper
• The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis

  2005cites this paper
• Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease

  2005cites this paper
• Infliximab induced chilblain lupus in a patient with rheumatoid arthritis.

  2005cites this paper
• [Juvenile idiopathic arthritis].

  2005cites this paper
• Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab.

  2005cites this paper
• Stellenwert der neuen Biologicals und Zytokinantagonisten in der Therapie der juvenilen idiopathischen Arthritis (JIA)

  2005cites this paper
• Artritis juveniles idiopáticas

  2005cites this paper
• The German etanercept registry for treatment of juvenile idiopathic arthritis

  2004cites this paper
• Etanercept - review of efficacy and safety after five years of clinical use

  2004cites this paper
• Safety of anti-TNFα therapy in children with juvenile idiopathic arthritis

  2004cites this paper
• Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis.

  2004cites this paper
• Arthrites juvéniles idiopathiques

  2004cites this paper
• The treatment of rheumatoid arthritis.

  2004cites this paper
• Advances in immunosuppressive treatment of juvenile idiopathic arthritis

  2003cites this paper
• Drugs acting on the immune system

  2003cites this paper
• Modalités actuelles de la prise en charge thérapeutique des arthrites juvéniles idiopathiques

  2003cites this paper
• Infections and biological therapy in rheumatoid arthritis.

  2003cites this paper
• Treatment of Autoimmune Disorders

  2003cites this paper
• Sarcoid-related uveitis occurring during etanercept therapy.

  2003cites this paper
• Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis

  2003cites this paper
• Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

  2003cites this paper
• Infection complications associated with the use of biologic agents.

  2003cites this paper
• Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents

  2002cites this paper
• Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis.

  2002cites this paper
• Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-α therapy and other novel approaches

  2002cites this paper
• Advanced therapy for juvenile arthritis.

  2002cites this paper
• [Gastrointestinal side effects in the therapy of rheumatologic diseases].

  2002cites this paper
• Development of rheumatoid nodules during anti–tumor necrosis factor α therapy with etanercept

  2002cites this paper
• Gastrointestinale Nebenwirkungen der Therapie rheumatischer Erkrankungen

  2002cites this paper
• Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.

  2002cites this paper
• TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides.

  2002cites this paper